OraPro-COVID-19

N/A

Report date: 2025/01/26 17:25:27

Base Information

Drug NameOraPro-COVID-19
Drug Alias Nameadeno-associated viral vectored vaccine(Stabilitech)adeno-associated viral vectored vaccine (iosBio)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesiosBio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesiosBio Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A